Literature DB >> 18989262

Synthesis of biotin-AMP conjugate for 5' biotin labeling of RNA through one-step in vitro transcription.

Faqing Huang1, Jun He, Yilin Zhang, Yanlin Guo.   

Abstract

Biotin-labeled RNA has found broad applications in chemistry, biology and biomedicine. In this protocol, we describe a simple procedure for 5' RNA biotin labeling by one-step in vitro transcription. A biotin-AMP (adenosine 5'-monophosphate) conjugate, biotin-HDAAMP (adenosine 5'-(6-aminohexyl) phosphoramide; where HDA is 1,6-hexanediamine), is chemically synthesized. Transcription initiation by biotin-HDAAMP under the T7 phi 2.5 promoter produces 5' biotin-labeled RNA with high labeling efficiency. The procedure is especially useful for biotin labeling of RNA that is larger than 60 nucleotides. In addition, the protocol provides an attractive alternative to chemical synthesis of biotin-labeled small RNA of less than 60 nucleotides, particularly when the desired quantity of RNA is low. The whole procedure, from chemical syntheses to isolated biotin-labeled RNA, can be completed within 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989262     DOI: 10.1038/nprot.2008.185

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  19 in total

Review 1.  Coming Together: RNAs and Proteins Assemble under the Single-Molecule Fluorescence Microscope.

Authors:  Ameya P Jalihal; Paul E Lund; Nils G Walter
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

Review 2.  Advances in methods for native expression and purification of RNA for structural studies.

Authors:  Robert T Batey
Journal:  Curr Opin Struct Biol       Date:  2014-02-28       Impact factor: 6.809

3.  Polymerase-Mediated Site-Specific Incorporation of a Synthetic Fluorescent Isomorphic G Surrogate into RNA.

Authors:  Yao Li; Andrea Fin; Lisa McCoy; Yitzhak Tor
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-21       Impact factor: 15.336

4.  Optimized method for the synthesis and purification of adenosine--folic acid conjugates for use as transcription initiators in the preparation of modified RNA.

Authors:  Brian M Laing; Peixuan Guo; Donald E Bergstrom
Journal:  Methods       Date:  2010-12-14       Impact factor: 3.608

Review 5.  Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Authors:  Yi Shu; Mathieu Cinier; Dan Shu; Peixuan Guo
Journal:  Methods       Date:  2011-02-12       Impact factor: 3.608

6.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

7.  Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network.

Authors:  Anca Chiriac; Timothy J Nelson; Randolph S Faustino; Atta Behfar; Andre Terzic
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  A T7 RNA Polymerase Mutant Enhances the Yield of 5'-Thienoguanosine-Initiated RNAs.

Authors:  Seth Lyon; Venkat Gopalan
Journal:  Chembiochem       Date:  2017-12-07       Impact factor: 3.164

9.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

10.  Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood.

Authors:  Rana Nagarkatti; Vaibhav Bist; Sirena Sun; Fernanda Fortes de Araujo; Hira L Nakhasi; Alain Debrabant
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.